Markets:

Overview

News

Currencies

International

Treasuries

Seelos Therapeutics, Inc. - Common Stock (NQ:SEEL)

1.280 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

June 28, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.03% at $0.85

Via Benzinga

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

June 27, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.12% at $0.82

Via Benzinga

Rebalanced Psychedelic Compounds-Based Drug Stocks Index Down 52.7% YTD ↗

June 27, 2022

The Psychedelic Compounds-Based Drug Stocks Index is down 52.7% YTD and down 75.9% from its highest point in 2021.

Via Talk Markets

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

June 24, 2022

GAINERS: Allied (OTC:ALID) shares closed up 29.44% at $0.56

Via Benzinga

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

June 23, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71

Via Benzinga

Psychedelic Stock Gainers And Losers From June 22, 2022 ↗

June 22, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50

Via Benzinga

Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

June 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31

Via Benzinga

Psychedelic Stock Gainers And Losers From June 17, 2022 ↗

June 17, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67

Via Benzinga

Psychedelic Stock Gainers And Losers From June 16, 2022 ↗

June 16, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From June 15, 2022 ↗

June 15, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62

Via Benzinga

World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health

June 15, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From June 14, 2022 ↗

June 14, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44

Via Benzinga

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗

June 13, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From June 10, 2022 ↗

June 10, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67

Via Benzinga

Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

June 09, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 09, 2022

Via Benzinga

Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

June 08, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78

Via Benzinga

Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

June 07, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72

Via Benzinga

ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗

June 06, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36

Via Benzinga

Jefferies Global Healthcare Conference: Three Psychedelic Biotech Companies To Participate This Week ↗

June 06, 2022

The 2022 Jefferies Global Healthcare Conference is an annual gathering where over 500 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity...

Via Benzinga

Psychedelic Stock Gainers And Losers From June 3, 2022 ↗

June 03, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35

Via Benzinga

Cybin, GH Research Among Top Psychedelic Movers Of Today ↗

June 02, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75

Via Benzinga

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry ↗

June 02, 2022

In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its...

Via Benzinga

ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗

June 01, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91

Via Benzinga

Psychedelic Stock Gainers And Losers From May 31, 2022 ↗

May 31, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36

Via Benzinga

Psychedelic Compounds-Based Stocks Continue To Decline ↗

May 29, 2022

Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share.

Via Talk Markets

Psychedelic Stock Gainers And Losers From May 26, 2022 ↗

May 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34

Via Benzinga

TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

May 25, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45

Via Benzinga

Psychedelic Stock Gainers And Losers From May 24, 2022 ↗

May 24, 2022

GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61

Via Benzinga

Cybin, Small Pharma Among Top Psychedelic Movers Of Today ↗

May 23, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.